|
|
|
|
|
|
|
|
Abstract
Conclusions:
These data confirm that loss of the ARID1A-encoded protein BAF250a is a frequent event in the genesis of clear cell and endometrioid ovarian cancers. Loss of BAF250a was not associated with clinical or epidemiologic characteristics. One explanation for these findings is that inactivation of the chromatin remodeling pathway may be a requisite event in the development of these cancers.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.